Skip to content
★ Sign in to follow
JT
Total declarations
202
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (137 ops.)
€39.1M

Latest filing published 21 Aug 2019 for bluebird bio, Inc., €11k.

Filing timeline

BuySale
Jeffrey T. Walsh

First 200 filings with a declared amount

Insider track record

Disclosed buys
0
Disclosed sells
137
Signal history

Jeffrey T. Walsh: trading record in brief

Jeffrey T. Walsh appears in our data through filings on bluebird bio, Inc. shares, published by SEC (Form 4). The record holds 202 filings, for trades running from 10 January 2014 to 20 August 2019.

The open-market record consists of 137 sales worth €39.1M, with no purchase. Besides market trades, the filings include 4 share grants and 61 option exercises. 2019 to date brings no purchases and 15 sales.

On 21 August 2019 came the latest disclosure, an option exercise for €11k in bluebird bio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Jeffrey T. Walsh

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations202 total
  • ◇
    Chief Strategy OfficerExecutivesbluebird bio, Inc.
    12,235 USD11SEC
    500 shares@ US$24.470.1% of flowCommon StockSEC:0001209191-19-046968:0
  • ▼
    Chief Strategy OfficerExecutivesbluebird bio, Inc.
    62,000 USD26SEC
    500 shares@ US$124.000.6% of flowCommon StockSEC:0001209191-19-046968:1
  • ◇
    Chief Strategy OfficerExecutivesbluebird bio, Inc.
    2,447 USD11SEC
    100 shares@ US$24.470.0% of flowCommon StockSEC:0001209191-19-038250:0
  • ▼
    Chief Strategy OfficerExecutivesbluebird bio, Inc.
    12,612 USD29SEC
    100 shares@ US$126.120.1% of flowCommon StockSEC:0001209191-19-038250:1
  • ◇
    Chief Strategy OfficerExecutivesbluebird bio, Inc.
    34,258 USD11SEC
    1,400 shares@ US$24.470.3% of flowCommon StockSEC:0001209191-19-036381:0
  • ▼
    Chief Strategy OfficerExecutivesbluebird bio, Inc.
    150,228 USD29SEC
    1,200 shares@ US$125.191.5% of flowCommon StockSEC:0001209191-19-036381:1
  • ▼
    Chief Strategy OfficerExecutivesbluebird bio, Inc.
    25,392 USD29SEC
    200 shares@ US$126.960.3% of flowCommon StockSEC:0001209191-19-036381:2
  • ▼
    Chief Strategy OfficerExecutivesbluebird bio, Inc.
    26,616 USD26SEC
    200 shares@ US$133.080.3% of flowCommon StockSEC:0001209191-19-029597:3
  • ▼
    Chief Strategy OfficerExecutivesbluebird bio, Inc.
    145,618 USD26SEC
    1,100 shares@ US$132.381.5% of flowCommon StockSEC:0001209191-19-029597:2
  • ◇
    Chief Strategy OfficerExecutivesbluebird bio, Inc.
    36,705 USD11SEC
    1,500 shares@ US$24.470.4% of flowCommon StockSEC:0001209191-19-029597:0
  • ▼
    Chief Strategy OfficerExecutivesbluebird bio, Inc.
    26,222 USD26SEC
    200 shares@ US$131.110.3% of flowCommon StockSEC:0001209191-19-029597:1
  • ◇
    Chief Strategy OfficerExecutivesbluebird bio, Inc.
    36,705 USD11SEC
    1,500 shares@ US$24.470.4% of flowCommon StockSEC:0001209191-19-024478:0
  • ▼
    Chief Strategy OfficerExecutivesbluebird bio, Inc.
    172,084 USD26SEC
    1,100 shares@ US$156.441.7% of flowCommon StockSEC:0001209191-19-024478:1
  • ▼
    Chief Strategy OfficerExecutivesbluebird bio, Inc.
    62,892 USD26SEC
    400 shares@ US$157.230.6% of flowCommon StockSEC:0001209191-19-024478:2
  • ◇
    Chief Strategy OfficerExecutivesbluebird bio, Inc.
    36,705 USD11SEC
    1,500 shares@ US$24.470.4% of flowCommon StockSEC:0001209191-19-019141:0
  • ▼
    Chief Strategy OfficerExecutivesbluebird bio, Inc.
    209,700 USD29SEC
    1,500 shares@ US$139.802.0% of flowCommon StockSEC:0001209191-19-019141:1
  • ◇
    Chief Financial andExecutivesbluebird bio, Inc.
    36,705 USD19SEC
    1,500 shares@ US$24.470.4% of flowCommon StockSEC:0001209191-19-009284:0
  • ▼
    Chief Financial andExecutivesbluebird bio, Inc.
    130,990 USD37SEC
    1,000 shares@ US$130.991.3% of flowCommon StockSEC:0001209191-19-009284:1
  • ▼
    Chief Financial andExecutivesbluebird bio, Inc.
    65,935 USD37SEC
    500 shares@ US$131.870.6% of flowCommon StockSEC:0001209191-19-009284:2
  • ◆
    Chief FinancialExecutivesbluebird bio, Inc.
    0SEC
    8,438 shares0Common StockSEC:0001209191-19-007459:0
  • ◇
    Chief FinancialExecutivesbluebird bio, Inc.
    73,410 USD19SEC
    3,000 shares@ US$24.470.7% of flowCommon StockSEC:0001209191-19-004541:0
  • ▼
    Chief FinancialExecutivesbluebird bio, Inc.
    375,420 USD37SEC
    3,000 shares@ US$125.143.6% of flowCommon StockSEC:0001209191-19-004541:1
  • ▼
    Chief FinancialExecutivesbluebird bio, Inc.
    224,201 USD37SEC
    1,979 shares@ US$113.292.1% of flowCommon StockSEC:0001209191-19-003092:0
  • ▼
    Chief FinancialExecutivesbluebird bio, Inc.
    118,082 USD37SEC
    1,033 shares@ US$114.311.1% of flowCommon StockSEC:0001209191-19-003092:1
  • ◇
    Chief FinancialExecutivesbluebird bio, Inc.
    36,705 USD19SEC
    1,500 shares@ US$24.470.2% of flowCommon StockSEC:0001209191-18-058508:0

25 of 202 declarations